v3.26.1
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of various warrants/options issued and outstanding
Schedule of various warrants/options issued and outstanding                              
Description of Warrant Number of Warrants   Issuable Shares   Exercise Price per Share   Weighted Average Remaining Life (Years)
Series B Warrants   75,000       178     $ 1.20       N/A (1)
January 2025 Warrants   449,193       37,433     $ 15.72 (2)     3.51  
Series A   19,564,585       75,172     $ 15.72 (3)     3.24  
2021 Warrants   514,290       437     $ 3,984.00       5.39  
2022 Repriced Warrants   88,803       77     $ 5,400.00       0.75  
2022 Warrants   59,202       61     $ 10,920.00       0.75  
Total   20,751,073       113,358                  

  

  (1) Series B Warrants do not have an expiration date.
  (2) Reflects January 2025 Warrants. In connection with the Warrant Inducement, the exercise price was reduced from $28.32 to $15.72 per share (post-Reverse Stock Split).
  (3) The Series A Warrants were part of the Warrant Inducement, and their exercise price was reduced from $62.472 to $15.72 per share (post-Reverse Stock Split).
Schedule of assumptions
Schedule of assumptions          
Warrant Stock Price (Post-Reverse Stock Split) Remaining Life (Years) Volatility Risk-Free Rate Dividend
Series A $24.24 4.12 129.9% 3.78%
January 2025 $24.24 4.39 129.9% 3.77%
Schedule of common stock shares reserved for future issuance
Schedule of common stock shares reserved for future issuance        
Exercise of 2021 and 2022 Warrants     575  
Exercise of Stock Options – 2021 Plan     17,844  
Exercise of Series A Warrants     75,172  
Exercise of Series B Warrants     178  
Exercise of January 2025 Warrants     37,433  
Exercise of Pre-Funded Warrants     12,042  
Settlement of RSUs     4,581  
Total shares of common stock reserved for future issuances     147,825